Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2386133.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of acromegaly diagnosed in the second trimester of pregnancy. Bromocriptine (7.5 mg per day) corrected visual field defects and suppressed prolactin secretion but did not reduce fasting growth hormone levels. We propose that suppression of physiologic lactotroph hyperplasia by bromocriptine may permit noninvasive management of pituitary adenomas during pregnancy.
Medical subject headings
- Acromegaly
- Adenoma
- Bromocriptine
- Pregnancy Complications, Neoplastic